← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
  1. Home
  2. BDX
  3. P/E History
OverviewAnalysisPriceRevenueEarningsP/ERatiosDividendTargets

BDX logoBecton, Dickinson and Company (BDX) P/E Ratio History

Historical price-to-earnings valuation from 1990 to 2026

Current P/E
26.3
Fair Value
5Y Avg P/E
27.2
-3% vs avg
PE Percentile
55%
Average
PEG Ratio
1.59
Moderate
TTM EPS$4.05
Price$153.26
5Y PE Range19.1 - 39.8
Earnings Yield3.80%

Loading P/E history...

BDX Valuation Context

How does the current P/E compare to historical and market benchmarks?

vs. 5Y Average
26.3vs27.2
-3%
In Line with History
vs. Healthcare
26.3vs22.3
+18%
Above Sector
vs. S&P 500
26.3vs25.1
+5%
In Line with Market
PEG Analysis
1.59
P/E ÷ EPS Growth
PEG 1-2 = Fair
Based on -1% EPS growth (1Y)
Export Data

P/E Ratio Analysis

As of May 8, 2026, Becton, Dickinson and Company (BDX) trades at a price-to-earnings ratio of 26.3x, with a stock price of $153.26 and trailing twelve-month earnings per share of $4.05.

The current P/E is roughly in line with its 5-year average of 27.2x. Over the past five years, BDX's P/E has ranged from a low of 19.1x to a high of 39.8x, placing the current valuation at the 55th percentile of its historical range.

Compared to the Healthcare sector median P/E of 22.3x, BDX trades at a 18% premium to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.

The PEG ratio of 1.59 (P/E divided by -1% EPS growth) suggests a fair valuation relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.

Relative to the broader market, BDX trades roughly in line with the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our BDX DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

BDX P/E vs Peers

P/E ratio compared to closely matched public peers

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
BSX logoBSXBoston Scientific Corporation
$84B29.2-+55%
MDT logoMDTMedtronic plc
$100B21.6-+31%
SYK logoSYKStryker Corporation
$113B35.02.36+8%
ZBH logoZBHZimmer Biomet Holdings, Inc.
$16B23.5--20%
EW logoEWEdwards Lifesciences Corporation
$48B45.26.39-74%
ABT logoABTAbbott Laboratories
$151B11.4Lowest0.38Best+134%Best
DHR logoDHRDanaher Corporation
$124B34.9--5%
TMO logoTMOThermo Fisher Scientific Inc.
$176B26.812.67+7%
HSIC logoHSICHenry Schein, Inc.
$8B21.66.84+7%

Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.

BDX Historical P/E Data (1990–2026)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterDatePriceTTM EPSP/E Ratiovs Avg
FY2026 Q2$157.23$3.9539.8x+70%
FY2026 Q1Wed Dec 31 2025 00:00:00 GM$152.56$6.1324.9x+6%
FY2025 Q4$115.68$5.8319.8x-15%
FY2025 Q3Mon Jun 30 2025 00:00:00 GM$106.45$5.5619.1x-18%
FY2025 Q2Mon Mar 31 2025 00:00:00 GM$141.57$5.2427.0x+15%
FY2025 Q1$140.23$6.0223.3x-1%
FY2024 Q4Mon Sep 30 2024 00:00:00 GM$149.01$5.9425.1x+7%
FY2024 Q3Sun Jun 30 2024 00:00:00 GM$144.44$4.8629.7x+27%
FY2024 Q2Sun Mar 31 2024 00:00:00 GM$152.95$4.5433.7x+44%
FY2024 Q1Sun Dec 31 2023 00:00:00 GM$150.69$4.2235.7x+52%
FY2023 Q4Sat Sep 30 2023 00:00:00 GM$159.79$4.9632.2x+37%
FY2023 Q3Fri Jun 30 2023 00:00:00 GM$163.18$5.5129.6x+26%

Average P/E for displayed period: 23.5x

Full BDX Stock Analysis

Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.

View Analysis

See BDX's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is BDX Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare BDX vs DBVT

Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..

Start Comparison

BDX — Frequently Asked Questions

Quick answers to the most common questions about buying BDX stock.

Is BDX stock overvalued or undervalued?

BDX trades at 26.3x P/E, near its 5-year average of 27.2x. The 55th percentile ranking places valuation within normal historical bounds.

How does BDX's valuation compare to peers?

Becton, Dickinson and Company P/E of 26.3x compares to sector median of 22.3x. The premium reflects expected growth above peers.

What is BDX's PEG ratio?

BDX PEG ratio is 1.59. Between 1-2 suggests valuation aligns with growth. Historical P/E data spans 1990-2026.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.

BDX P/E Ratio History (1990–2026)

P/E ratio calculated as closing price divided by trailing 12-month diluted EPS at each quarter end.